NWY001

· Chipscreen Biosciences, Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NWY001, covering 2024-07-16 to 2024-07-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study of NWY001 in Subjects With Advanced Solid Tumors [Phase 1]